The Full ASGCT 27th Annual Meeting Abstracts Collection is NOW LIVE! Click here to read the full collection.
The first quarterly report of 2023 from ASGCT and Citeline is available now! The Gene, Cell, & RNA Therapy Landscape report is the only field-wide report covering the therapeutics pipeline, clinical targets, developer progress, and more.
Highlights from this issue include:
An mRNA vaccine was approved for COVID-19 prophylaxis in China
Vyznova, a non-genetically modified cell therapy, was approved for corneal dystrophy in Japan
Hemgenix was approved for hemophilia B in the EU and UK
Download the full report
May 7-11, 2024 | Baltimore, MD
© 2000-2024 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico